Latest Industry Insights

Microscopy is a key tool in many areas of research, but what happens when what you want to study is in a remote location, doesn’t transport well or you need instant answers? Well, then the analysis has to go to the sample. We spoke to Andrew Monk, cofounder of ioLight, about ioLight’s conception and what makes it so special.

In this interview, Aaron Hudson, Vice President & General Manager, Global Marketing & Strategy at SCIEX, discusses why precision quantification, specifically quantitative mass spectrometry (MS), is the best approach for measuring the transition from "wellness" to illness.

How can vendors ensure their technologies are less complex, and therefore available to a wider range of users, without compromising on the quality of data?

Imagine if there was a better way to write, format, and review scientific manuscripts for publication. doDOC Document Collaboration Expert Leif Måsvær believes there is. Leif explains how this cloud-based platform is a game-changer that overcomes the major obstacles present during the authoring, writing, and reviewing process.

In this interview, we spoke with Knut Wintergerst, PhD, General Manager of Biomolecular Systems and Solutions (BSS) and Diagnostics and Genomics Group (DGG) at Agilent to learn more about why DNA and RNA sample integrity is important to scientists and how it can be maintained and analyzed.

Earlier in 2019, Waters Corporation announced their BioAccord LC-MS System for biopharmaceutical analysis. We spoke with John Gebler, PhD, Director of Strategic Business Development at Waters Corporation to learn more about the BioAccord System and its applications.

Pupillometry is an ingenious way of assessing brain health by measuring data from patients’ eyes. New technology has helped standardize pupillometry, and these measurements are now helping treat patients with life-threatening brain injuries. We spoke to Kathleen Pierson, Vice President, Global Sales and Marketing, at pupillometry leader NeurOptics, to find out more.

Whilst some aspects of biochemistry research have become increasingly high-throughput, other, like analysis of chemical data, are too often laborious and slow. We talked to Andrew Anderson, Vice President of Innovation and Informatics Strategy at ACD/Labs about how the field is being changed by automation and how Katalyst hopes to speed up pharmaceutical development.

By studying gene expression modifications induced by the immune response, Novigenix has developed a blood test for colorectal cancer. This Q&A with Jan Groen, CEO, provides insights on the test, and on the field of study that could revolutionize cancer diagnosis.

To ensure safety and consistency of products within the food industry, continual analysis through the production process is essential. We spoke to Ian Olmsted, from CEM Corporation, about ORACLE, an innovative solution that enables analysts to measure fat in food and much more without the fuss of traditional techniques.